Search for…

• Efficacy boost for dendritic cell therapies

  B73083

  Efficacy boost for dendritic cell therapies

  • Method to increase efficacy of existing DC-based cell therapies
  • Enzymatic treatment improves T-cell priming capacity up to 10-fold
  • Results in strong proliferation of tumor-killing T-cells
• Highly promising AML treatment option targeting leukemic blasts and stem cells

  B78209

  Highly promising AML treatment option targeting leukemic blasts and stem cells

  • Long-lasting elimination of leukemic blasts and leukemic stem cells
  • Suitable for all AML patients
  • Low side effects
• Novel ¹⁸F-labeled PET tracers targeting RAS for cardiology and oncology

  B77016

  Novel ¹⁸F-labeled PET tracers targeting RAS for cardiology and oncology

  • Simple, low-cost synthesis, long tracer half-life
  • Specifically targets Renin-Angiotensin-Aldosterone-System (RAS)
  • For PET diagnostic
• Highly Active and Selective Ligands for ­Integrin avß6

  B75165

  Highly Active and Selective Ligands for ­Integrin avß6

  • Highly upregulated avß6 in different types of cancer
  • Peptides with remarkable affinity and high selctivity
  • No binding affinity toward other RGD-recognizing integrins
• Prognostic and predictive Biomarker for Melanoma

  B78091

  Prognostic and predictive Biomarker for Melanoma

  • Prognostic test for patients with malignant melanoma
  • Estimates patient life expectancy
  • Biomarker for predicts melanoma therapy response

5 of 90 Tech Offers